Cargando…
Systemic Lupus Erythematosus May Be a Risk Factor for Antimalarial‐Induced Retinopathy Compared With Other Rheumatologic Diseases
OBJECTIVE: To describe the pattern and risk factors for antimalarial (AM)‐induced retinopathy in patients with rheumatic diseases. METHODS: A retrospective chart review was conducted at an urban Canadian center for patients with AM use of more than 3 months and documented retinopathy screening. Univ...
Autores principales: | Liu, Hsin Yen, Cramarossa, Gemma, Pope, Janet E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100695/ https://www.ncbi.nlm.nih.gov/pubmed/36787153 http://dx.doi.org/10.1002/acr2.11531 |
Ejemplares similares
-
Lupus Erythematosus Panniculitis in Pregnancy and Antimalarials
por: Srivastava, Ankita
Publicado: (2016) -
Role of lupus retinopathy in systemic lupus erythematosus
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2016) -
Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies
por: Li, Xian-Bao, et al.
Publicado: (2021) -
Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus
por: Ugarte-Gil, Manuel F., et al.
Publicado: (2023) -
Prescription strategy of antimalarials in cutaneous and systemic
lupus erythematosus: an international survey
por: Petitdemange, Arthur, et al.
Publicado: (2021)